Indiana life sciences companies raise significant venture dollars

A new report from BioCrossroads shows dramatic gains in venture capital funding in Indiana’s life sciences sector. In 2022, 39 companies raised a total of $619 million. This is a 136% increase over 2020’s $262 million and a 65% increase over 2021’s $433 million. Since a comparable number of companies raised capital in those years, the report attributes the gains to an increase in average deal size. Additionally, there was a $124 million funding round for one agtech company,  Inari. Had that investment not occurred there still would have been a 14% year-over-year increase.

Download the full report

Follow Me

Ben Keeton

Publisher at Medical News
Ben is the publisher of Medical News and focuses on the business of healthcare in Kentucky.
Follow Me